These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7678092)

  • 1. Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
    Truong LD; Kadmon D; McCune BK; Flanders KC; Scardino PT; Thompson TC
    Hum Pathol; 1993 Jan; 24(1):4-9. PubMed ID: 7678092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
    Cohen P; Nunn SE; Peehl DM
    J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
    Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
    Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
    Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
    Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors.
    Glynne-Jones E; Harper ME; Goddard L; Eaton CL; Matthews PN; Griffiths K
    Prostate; 1994 Oct; 25(4):210-8. PubMed ID: 7521962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions.
    Leav I; McNeal JE; Ziar J; Alroy J
    Hum Pathol; 1998 Jul; 29(7):668-75. PubMed ID: 9670822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma.
    Djonov V; Ball RK; Graf S; Mottaz AE; Arnold AM; Flanders K; Studer UE; Merz VW
    Prostate; 1997 May; 31(2):103-9. PubMed ID: 9140123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
    Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
    Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.
    Jackson MW; Bentel JM; Tilley WD
    J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
    Timme TL; Yang G; Truong LD; Kadmon D; Park SH; Thompson TC
    World J Urol; 1995; 13(6):324-8. PubMed ID: 9116750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.